Character Biosciences
PrivateLast Round
Series B
Sep 17, 2025
Est. Valuation
$197M
Total Funding Raised
$221M
Company Overview
Character Biosciences is a biotechnology company that develops precision medicine and targeted therapies for progressive polygenic diseases, with an initial focus on ophthalmology.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Character Biosciences Comps
Public and private peers based on sector, stage, and business model.
Character Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 17, 2025 | ||||
| Series B | Mar 25, 2025 | ||||
| Series A | May 17, 2022 |
Character Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A, Series B |
| Cantos Ventures | Series A |
| Innovation Endeavors | Series B, Series A |
| Lifeforce Capital | Series A |
| Catalio Capital Management | Series B, Series A |
| LUMA Partners | Series B |
| Jefferson Life Sciences | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Partnering with Bausch + Lomb to develop precision medicines for AMD.
- Oct 13, 2025
Collaborating with Bausch + Lomb on precision medicines for AMD.
Character Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Character Biosciences's valuation, stock price, and market status.
